Highlights • High-risk multi-agent drug resistant GTN is a life threatening disease.• Majority of choriocarcinomas show intense PD-L1 immunoreactivity.• Pembrolizumab increases antitumor activity.• Effectiveness of Pembrolizumab in treating patients with… Click to show full abstract
Highlights • High-risk multi-agent drug resistant GTN is a life threatening disease.• Majority of choriocarcinomas show intense PD-L1 immunoreactivity.• Pembrolizumab increases antitumor activity.• Effectiveness of Pembrolizumab in treating patients with high-risk multi-agent drug resistant GTN.
               
Click one of the above tabs to view related content.